ABIVAX Société Anonyme

OTCPK:AAVX.F Stock Report

Market Cap: US$952.3m

ABIVAX Société Anonyme Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Marc M. de Garidel

Chief executive officer

€794.0k

Total compensation

CEO salary percentage45.3%
CEO tenureless than a year
CEO ownership0.06%
Management average tenureless than a year
Board average tenure5.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Marc M. de Garidel's remuneration changed compared to ABIVAX Société Anonyme's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023€794k€359k

-€148m

Compensation vs Market: Marc M.'s total compensation ($USD854.74K) is below average for companies of similar size in the US market ($USD3.42M).

Compensation vs Earnings: Insufficient data to compare Marc M.'s compensation with company performance.


CEO

Marc M. de Garidel (65 yo)

less than a year

Tenure

€793,971

Compensation

Mr. Marc M. P. de Garidel, M.B.A., serves as Director of Claris Biotherapeutics, Inc. He serves as CEO & Interim Chair of Board at ABIVAX Société Anonyme since May 5, 2023. He has been the Chief Executive...


Leadership Team

NamePositionTenureCompensationOwnership
Marc M. de Garidel
CEO & Interim Chair of Boardless than a year€793.97k0.061%
€ 577.4k
Philippe Pouletty
Founder & Directorno datano data0.44%
€ 4.2m
Didier Blondel
EVP, CFO & Board Secretary7.3yrsno data0.00059%
€ 5.6k
Didier Scherrer
Chief Scientific Officerless than a yearno data0.057%
€ 541.5k
Patrick Malloy
Senior Vice President of Investor Relationsless than a yearno datano data
Ida Hatoum
Chief People Officerless than a yearno datano data
Pierre Courteille
Chief Business Officerno datano data0%
€ 0
Jérôme Denis
Executive Vice President of Process Development & Manufacturingless than a yearno datano data
Sheldon Sloan
Chief Medical Officer1.2yrsno datano data
Michael Ferguson
Chief Commercial Officer1.1yrsno datano data
Ana Sharma
VP & Global Head of Qualityless than a yearno datano data

0.9yrs

Average Tenure

56.5yo

Average Age

Experienced Management: AAVX.F's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Marc M. de Garidel
CEO & Interim Chair of Boardless than a year€793.97k0.061%
€ 577.4k
Philippe Pouletty
Founder & Director10.4yrsno data0.44%
€ 4.2m
Christian Brechot
Member of Scientific Advisory Board6.6yrsno datano data
Christian Trepo
Member of Scientific Advisory Boardno datano datano data
Lawrence Stanberry
Member of Scientific Advisory Boardno datano datano data
Troy Ignelzi
Independent Directorless than a year€44.33kno data
Christoph Huber
Member of Scientific Advisory Boardno datano datano data
Claude Bertrand
Member of Scientific Advisory Board4.6yrs€4.94kno data
Luc Teyton
Member of Scientific Advisory Boardno datano datano data
June Lee
Independent Directorless than a year€35.24kno data
Corinna Bonsen-Thomas
Independent Non-Executive Director6.9yrs€135.16k0%
€ 0
Ian McGowan
Chairman of Scientific Advisory Board5.9yrsno datano data

5.3yrs

Average Tenure

64yo

Average Age

Experienced Board: AAVX.F's board of directors are considered experienced (5.3 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.